Cover Image

Mannheim intima-media thickness consensus: on Behalf of the Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference, Mannheim, Germany, May 14, 200

Intima-media thickness (IMT) is increasingly used in clinical trials as a surrogate end point for determining the success of interventions that lower risk factors for atherosclerosis. The necessity for unified criteria to distinguish early atherosclerotic plaque formation from thickening of IMT and...

Full description

Saved in:
Bibliographic Details
Main Authors: Touboul, Pierre-Jean (Author) , Hennerici, Michael G. (Author) , Meairs, S. (Author) , Adams, H. (Author) , Amarenco, P. (Author) , Desvarieux, M. (Author) , Ebrahim, S. (Author) , Fatar, M. (Author) , Hernandez Hernandez, R. (Author) , Kownator, S. (Author) , Prati, P. (Author) , Rundek, T. (Author) , Taylor, A. (Author) , Bornstein, N. (Author) , Csiba, L. (Author) , Vicaut, E. (Author) , Woo, K. S. (Author) , Zannad, F. (Author)
Format: Article (Journal)
Language:English
Published: November 2, 2004
In: Cerebrovascular diseases
Year: 2004, Volume: 18, Issue: 4, Pages: 346-349
ISSN:1421-9786
DOI:10.1159/000081812
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000081812
Get full text
Author Notes:P.-J. Touboul, M.G. Hennerici, S. Meairs, H. Adams, P. Amarenco, M. Desvarieux, S. Ebrahim, M. Fatar, R. Hernandez Hernandez, S. Kownator, P. Prati, T. Rundek, A. Taylor, N. Bornstein, L. Csiba, E. Vicaut, K.S. Woo, F. Zannad
Description
Summary:Intima-media thickness (IMT) is increasingly used in clinical trials as a surrogate end point for determining the success of interventions that lower risk factors for atherosclerosis. The necessity for unified criteria to distinguish early atherosclerotic plaque formation from thickening of IMT and to standardize IMT measurements is addressed in this consensus statement. Plaque is defined as a focal structure that encroaches into the arterial lumen of at least 0.5 mm or 50% of the surrounding IMT value or demonstrates a thickness of > or =1.5 mm as measured from the media-adventitia interface to the intima-lumen interface. Standard use of IMT measurements is recommended in all epidemiological and interventional trials dealing with vascular diseases to improve characterization of the population investigated. The consensus concludes that there is no need to 'treat IMT values' nor to monitor IMT values in individual patients apart from few exceptions. Although IMT has been suggested to represent an important risk marker, it does not fulfill the characteristics of an accepted risk factor. Standardized methods recommended in this consensus statement will foster homogenous data collection and analysis. This will help to improve the power of studies incorporating IMT measurements and to facilitate the merging of large databases for meta-analyses.
Item Description:Gesehen am 19.05.2022
Physical Description:Online Resource
ISSN:1421-9786
DOI:10.1159/000081812

Similar Items